Total Voting Rights
MYDECINE INNOVATIONS GROUP INC. (the "Company" or "Mydecine") TOTAL VOTING RIGHTS VANCOUVER, BC – (30 April 2024) In accordance with the FCA's Disclosure Guidance and Transparency Rules, as at 30 April 2024, the Company’s issued share capital consists of 61,755,385 Ordinary Shares of no par value, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 61,755,385. The above figure of 61,755,385 should be used by shareholders in the Company as the denominator for the